PGAM5 is a key driver of mitochondrial dysfunction in experimental lung fibrosis
Mitochondrial homeostasis has recently emerged as a focal point in the pathophysiology of idiopathic pulmonary fibrosis (IPF), but conflicting data have been reported regarding its regulation. We speculated that phosphoglycerate mutase family member 5 (PGAM5), a mitochondrial protein at the intersec...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
5 June 2019
|
| In: |
Cellular and molecular life sciences
Year: 2019, Jahrgang: 76, Heft: 23, Pages: 4783-4794 |
| ISSN: | 1420-9071 |
| DOI: | 10.1007/s00018-019-03133-1 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00018-019-03133-1
|
| Verfasserangaben: | Ingo Ganzleben, Gui-Wei He, Claudia Günther, Elena-Sophie Prigge, Karsten Richter, Ralf J. Rieker, Dimitrios Mougiakakos, Markus F. Neurath, Christoph Becker |
| Zusammenfassung: | Mitochondrial homeostasis has recently emerged as a focal point in the pathophysiology of idiopathic pulmonary fibrosis (IPF), but conflicting data have been reported regarding its regulation. We speculated that phosphoglycerate mutase family member 5 (PGAM5), a mitochondrial protein at the intersection of multiple cell death and mitochondrial turnover pathways, might be involved in the pathogenesis of IPF. |
|---|---|
| Beschreibung: | Gesehen am 30.03.2020 |
| Beschreibung: | Online Resource |
| ISSN: | 1420-9071 |
| DOI: | 10.1007/s00018-019-03133-1 |